CU6
Asset Logo

Clarity Pharmaceuticals Ltd

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ“ฆ LOGISTICS

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

+ 60.45%
Annual Growth

3 years average annual growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

68
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. The company is headquartered in Eveleigh, New South Wales. The company went IPO on 2021-08-25. The firm is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. The company is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. The company has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.

๐Ÿ“ˆ Performance

Price History

+201.43%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$4.22

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in CU6

68

๐Ÿ“Š Total Capital Earnings

$213K

๐Ÿ”ƒ Average investment frequency

28 weeks

๐Ÿ’ต Average investment amount

$2,658

โฐ Last time a customer invested in CU6

13 hours
CU6 investor breakdown
๐Ÿ’ต Income of investors

More than 200k

7%

150k - 200k

100k - 150k

19%

50k - 100k

45%

Less than 50k

26%
๐Ÿ‘ถ Age of investors

18 - 25

9%

26 - 34

34%

35 - 90

57%
๐Ÿ™‹ Legal gender of investors

Female

54%

Male

46%

Pearlers who invest in CU6 also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

3.62%

๐Ÿ“Š Share price

$102.10 AUD

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

โ›ณ๏ธ DIVERSIFIED

๐Ÿงฑ MATERIALS

๐Ÿ’ธ FINANCIALS

Find Out More

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

14.02%

๐Ÿ“Š Share price

$140.20 AUD

โ›ณ๏ธ DIVERSIFIED

๐Ÿ“ˆ HIGH PRICE GROWTH

๐ŸŒ GLOBAL

๐Ÿค– TECHNOLOGY

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

๐Ÿ™Œ Performance (5Yr p.a)

20.56%

๐Ÿ“Š Share price

$63.57 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The company develops a portfolio of clinical and commercial stage products that addresses significant unmet medical needs in oncology and rare diseases. The company operates a pipeline of theranostic radiopharmaceutical product candidates with a focus in urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning. The company operates under four business units: Therapeutics, Precision Medicine (Diagnostics), Lightpoint (Medtech), and Telix Manufacturing Solutions (TMS). Its lead imaging product is gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix). Its other pipelines include TLX591, TLX592, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx.

๐Ÿ™Œ Performance (5Yr p.a)

307.18%

๐Ÿ“Š Share price

$24.62 AUD

๐Ÿงฌ BIOTECHNOLOGY

DroneShield Ltd. engages in the development and commercialisation of hardware and software technology for drone detection and security. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-06-22. The company provides artificial intelligence-based platforms for protection against advanced threats, such as drones and autonomous systems. The company offers customers bespoke counter-drone (or counter-UAS) and electronic warfare solutions and off-the-shelf products designed to suit a variety of terrestrial, maritime, or airborne platforms. The Companyโ€™s products include DroneGun Tactical, DroneGun MKIII, DroneSentry, DroneSentry-C2, DroneSentry-X, RfPatrol and DroneSim among others. The DroneGun Tactical is an unmanned aerial systems (UAS) countermeasure designed for two-hand operation and long-range defeat. RfPatrol is a passive/non-emitting wearable UAS detection device. The Companyโ€™s capabilities include C-UAS, C-UxS Training, and Electronic Warfare.

๐Ÿ™Œ Performance (5Yr p.a)

31.37%

๐Ÿ“Š Share price

$0.66 AUD

๐Ÿš€ AEROSPACE & DEFENSE

๐Ÿ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

Cue Energy Resources Ltd. engages in the exploration, development and production of oil and gas. The company is headquartered in Melbourne, Victoria. In Australia, it has interests in three production assets, Mereenie, Palm Valley, and Dingo Fields, situated in the Amadeus Basin within the onshore Northern Territory. The Mereenie field produces gas which is transported through the Northern Gas pipeline to serve the Eastern Australia gas market. The Palm Valley field is 100 kilometers west of Alice Springs and produces gas, which is transported through the Amadeus and Northern Gas pipeline and sold into the Northern Territory and Eastern Australia gas markets. The Dingo field produces gas, which is processed at the Brewer Estate processing facility located near Alice Springs. In New Zealand, it holds a 5% interest Petroleum Mining Permit (PMP) 38160, which contains the Maari and Manaia producing oilfields. In Indonesia, it holds interests in Mahato PSC and Sampang PSC.

๐Ÿ™Œ Performance (5Yr p.a)

-3.83%

๐Ÿ“Š Share price

$0.10 AUD

โšก๏ธ ENERGY

CuFe Ltd. operates as an exploration company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2005-10-13. Its main focus is its mature iron ore assets in Western Australia (JWD Iron Ore Project) and the Northern Territory (Yarram Iron Ore Project) and copper asset (Tennant Creek Copper Project). The JWD Iron Ore Project is located in Western Australia, 700 kilometers from Geraldton Port. The company holds a 50% interest in Gold Valley Iron and Manganese Pty Ltd, the owner of the iron ore rights over the Yarram project. The company owns 55% interest in the Tennant Creek project. The company owns West Arunta (niobium) and Tambourah (lithium) exploration tenure. The company owns North Dam Lithium and Rare Earths Project- E 15/1495, M15/1893 (certain mineral rights), and M15/1495. Its other projects include Bryah Basin Joint Venture Projects, Morck Well Project, Peak Hill Project and Mt Ida Iron Ore Project.

๐Ÿ™Œ Performance (5Yr p.a)

-6.15%

๐Ÿ“Š Share price

$0.01 AUD

โ›๏ธ MINING

Careteq Ltd. engages in the development, design, and commercialization of assisted-living technology products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-10. The firm is using its early-mover advantage in the Assistive Living Technology sector to revolutionize aged and disability care across the globe. Its brands include Sofihub, TEQ-FallsAlert and Embedded Health Solutions (EHS). The Sofihub brand is an advanced adaptive care technology that gives people of all ages and abilities the freedom to live independently, while reducing their reliance on family or professional careers. Sofihub has developed a suite of intelligent adaptive technology that enables the aged and at-risk members of society to live independently. TEQ-FallsAlert powered by Sofihub employs radar technology that provides continuous non-invasive monitoring, allowing care resources to be managed efficiently. EHS helps health care workers with professional knowledge and advice to help prevent incidents of medicine-related harm.

๐Ÿ“Š Share price

$0.01 AUD

๐Ÿฉบ HEALTH CARE

Cettire Ltd. is an online luxury goods retailer, which engages in luxury personal items such as clothing, shoes, bags, and accessories via their website. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-18. The firm is engaged in offering a selection of in demand personal luxury goods via its Website, cettire.com. The company has access to an extensive catalogue of more than 2,500 luxury brands and 500,000 products of clothing, shoes, bags, and accessories. The company sells a range of products from over 500 designers, which include a range of women's and men's wear from brands, such as Prada, Gucci, Saint Laurent, Balenciaga, and Valentino, among others. The firm's product categories include clothing, shoes, bags, and accessories. Its clothing category offers activewear, coats, jackets, jeans, knitwear, pants, and various others. Its shoes category offers boots, espadrilles, lace-up shoes, loafers, and various others. The Companyโ€™s bags category offers bag accessories, belt bags, clutch bags, crossbody bags and various others. The firm also offers accessories, such as belts, glasses, gloves, hats, and various others.

๐Ÿ“Š Share price

$1.42 AUD

๐Ÿ›๏ธ CONSUMER

Compare
Add to watchlist